Home » Life & Medical » Research on Intravenous (IV) Iron Drugs Market 2016-2020 and Forecast 2021-2026

Research on Intravenous (IV) Iron Drugs Market 2016-2020 and Forecast 2021-2026

  94 Pages     Life & Medical  

Available Formats      

Report ID: 70486
Published By: 99Strategy

Summary

The Global Intravenous (IV) Iron Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Intravenous (IV) Iron Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Ferric Carboxymaltose

Iron Sucrose

Iron Dextran

Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

Sanofi US

Allergan

AMAG Pharmaceuticals

Dalichi Sankyo

Luitpold Pharmaceuticals

Pharmacosmos

Takeda Pharmaceutical

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Nephrology

Gynecology & Obstetrics

Gastroenterology

Oncology

Cardiology

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Industry Overview

1.1 Intravenous (IV) Iron Drugs Industry

Figure Intravenous (IV) Iron Drugs Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Intravenous (IV) Iron Drugs

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Intravenous (IV) Iron Drugs

1.2.2 Downstream

Table Application Segment of Intravenous (IV) Iron Drugs

Table Global Intravenous (IV) Iron Drugs Market 2016-2026, by Application, in USD Million

1.2.3 COVID-19 Impact

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Intravenous (IV) Iron Drugs Market by Type

3.1 By Type

3.1.1 Ferric Carboxymaltose

Table Major Company List of Ferric Carboxymaltose

3.1.2 Iron Sucrose

Table Major Company List of Iron Sucrose

3.1.3 Iron Dextran

Table Major Company List of Iron Dextran

3.1.4 Others

Table Major Company List of Others

3.2 Market Size

Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Type, in USD Million

Figure Global Intravenous (IV) Iron Drugs Market Growth 2016-2020, by Type, in USD Million

Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Type, in Volume

Figure Global Intravenous (IV) Iron Drugs Market Growth 2016-2020, by Type, in Volume

3.3 Market Forecast

Table Global Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Type, in USD Million

Table Global Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Type, in Volume

4 Major Companies List

4.1 Sanofi US (Company Profile, Sales Data etc.)

4.1.1 Sanofi US Profile

Table Sanofi US Overview List

4.1.2 Sanofi US Products & Services

4.1.3 Sanofi US Business Operation Conditions

Table Business Operation of Sanofi US (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Allergan (Company Profile, Sales Data etc.)

4.2.1 Allergan Profile

Table Allergan Overview List

4.2.2 Allergan Products & Services

4.2.3 Allergan Business Operation Conditions

Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 AMAG Pharmaceuticals (Company Profile, Sales Data etc.)

4.3.1 AMAG Pharmaceuticals Profile

Table AMAG Pharmaceuticals Overview List

4.3.2 AMAG Pharmaceuticals Products & Services

4.3.3 AMAG Pharmaceuticals Business Operation Conditions

Table Business Operation of AMAG Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Dalichi Sankyo (Company Profile, Sales Data etc.)

4.4.1 Dalichi Sankyo Profile

Table Dalichi Sankyo Overview List

4.4.2 Dalichi Sankyo Products & Services

4.4.3 Dalichi Sankyo Business Operation Conditions

Table Business Operation of Dalichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Luitpold Pharmaceuticals (Company Profile, Sales Data etc.)

4.5.1 Luitpold Pharmaceuticals Profile

Table Luitpold Pharmaceuticals Overview List

4.5.2 Luitpold Pharmaceuticals Products & Services

4.5.3 Luitpold Pharmaceuticals Business Operation Conditions

Table Business Operation of Luitpold Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Pharmacosmos (Company Profile, Sales Data etc.)

4.6.1 Pharmacosmos Profile

Table Pharmacosmos Overview List

4.6.2 Pharmacosmos Products & Services

4.6.3 Pharmacosmos Business Operation Conditions

Table Business Operation of Pharmacosmos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Takeda Pharmaceutical (Company Profile, Sales Data etc.)

4.7.1 Takeda Pharmaceutical Profile

Table Takeda Pharmaceutical Overview List

4.7.2 Takeda Pharmaceutical Products & Services

4.7.3 Takeda Pharmaceutical Business Operation Conditions

Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Intravenous (IV) Iron Drugs Sales Revenue 2016-2020, by Company, in USD Million

Table Global Intravenous (IV) Iron Drugs Sales Revenue Share 2016-2020, by Company, in USD Million

Figure Global Intravenous (IV) Iron Drugs Sales Revenue Share in 2020, by Company, in USD Million

Table Global Intravenous (IV) Iron Drugs Sales Volume 2016-2020, by Company, in Volume

Table Global Intravenous (IV) Iron Drugs Sales Volume Share 2016-2020, by Company, in Volume

Figure Global Intravenous (IV) Iron Drugs Sales Volume Share in 2020, by Company, in Volume

5.2 Regional Market by Company

Figure North America Intravenous (IV) Iron Drugs Market Concentration, in 2020

Figure Europe Intravenous (IV) Iron Drugs Market Market Concentration, in 2020

Figure Asia-Pacific Intravenous (IV) Iron Drugs MMarket Concentration, in 2020

Figure South America Intravenous (IV) Iron Drugs Market Concentration, in 2020

Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Concentration, in 2020

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Nephrology

Figure Intravenous (IV) Iron Drugs Demand in Nephrology, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Nephrology, 2016-2020, in Volume

6.1.2 Demand in Gynecology & Obstetrics

Figure Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2016-2020, in Volume

6.1.3 Demand in Gastroenterology

Figure Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2016-2020, in Volume

6.1.4 Demand in Oncology

Figure Intravenous (IV) Iron Drugs Demand in Oncology, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Oncology, 2016-2020, in Volume

6.1.5 Demand in Cardiology

Figure Intravenous (IV) Iron Drugs Demand in Cardiology, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Cardiology, 2016-2020, in Volume

6.1.6 Demand in Others

Figure Intravenous (IV) Iron Drugs Demand in Others, 2016-2020, in USD Million

Figure Intravenous (IV) Iron Drugs Demand in Others, 2016-2020, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Intravenous (IV) Iron Drugs Demand Forecast 2021-2026, by Application, in USD Million

Figure Intravenous (IV) Iron Drugs Market Growth 2021-2026, by Application, in USD Million

Figure Intravenous (IV) Iron Drugs Market Share in 2026, by Application, in USD Million

Table Intravenous (IV) Iron Drugs Demand Forecast 2021-2026, by Application, in Volume

Table Intravenous (IV) Iron Drugs Market Growth 2021-2026, by Application, in Volume

Table Intravenous (IV) Iron Drugs Market Share in 2026, by Application, in Volume

6.4 Impact of the COVID-19 on the Demand

7 Region Operation

7.1 Regional Production

Table Intravenous (IV) Iron Drugs Production 2016-2020, by Region, in USD Million

Table Intravenous (IV) Iron Drugs Production 2016-2020, by Region, in Volume

7.2 Regional Market

Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Region, in USD Million

Table Global Intravenous (IV) Iron Drugs Market Share 2016-2020, by Region, in USD Million

Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Region, in Volume

Table Global Intravenous (IV) Iron Drugs Market Share 2016-2020, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

Figure North America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

Table North America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

Figure Europe Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

Table Europe Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

Figure South America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

Table South America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

Table Middle East & Africa Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Region, in USD Million

Table Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

1. Table Upstream Segment of Intravenous (IV) Iron Drugs

2. Table Application Segment of Intravenous (IV) Iron Drugs

3. Table Global Intravenous (IV) Iron Drugs Market 2016-2026, by Application, in USD Million

4. Table Major Company List of Iron Sucrose

5. Table Major Company List of Iron Dextran

6. Table Major Company List of Others

7. Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Type, in USD Million

8. Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Type, in Volume

9. Table Global Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Type, in USD Million

10. Table Global Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Type, in Volume

11. Table Sanofi US Overview List

12. Table Business Operation of Sanofi US (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

13. Table Allergan Overview List

14. Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

15. Table AMAG Pharmaceuticals Overview List

16. Table Business Operation of AMAG Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

17. Table Dalichi Sankyo Overview List

18. Table Business Operation of Dalichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

19. Table Luitpold Pharmaceuticals Overview List

20. Table Business Operation of Luitpold Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

21. Table Pharmacosmos Overview List

22. Table Business Operation of Pharmacosmos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

23. Table Takeda Pharmaceutical Overview List

24. Table Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

25. Table Global Intravenous (IV) Iron Drugs Sales Revenue 2016-2020, by Company, in USD Million

26. Table Global Intravenous (IV) Iron Drugs Sales Revenue Share 2016-2020, by Company, in USD Million

27. Table Global Intravenous (IV) Iron Drugs Sales Volume 2016-2020, by Company, in Volume

28. Table Global Intravenous (IV) Iron Drugs Sales Volume Share 2016-2020, by Company, in Volume

29. Table Regional Demand Comparison List

30. Table Major Application in Different Regions

31. Table Intravenous (IV) Iron Drugs Demand Forecast 2021-2026, by Application, in USD Million

32. Table Intravenous (IV) Iron Drugs Demand Forecast 2021-2026, by Application, in Volume

33. Table Intravenous (IV) Iron Drugs Market Growth 2021-2026, by Application, in Volume

34. Table Intravenous (IV) Iron Drugs Market Share in 2026, by Application, in Volume

35. Table Intravenous (IV) Iron Drugs Production 2016-2020, by Region, in USD Million

36. Table Intravenous (IV) Iron Drugs Production 2016-2020, by Region, in Volume

37. Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Region, in USD Million

38. Table Global Intravenous (IV) Iron Drugs Market Share 2016-2020, by Region, in USD Million

39. Table Global Intravenous (IV) Iron Drugs Market 2016-2020, by Region, in Volume

40. Table Global Intravenous (IV) Iron Drugs Market Share 2016-2020, by Region, in Volume

41. Table North America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

42. Table North America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

43. Table Europe Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

44. Table Europe Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

45. Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

46. Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

47. Table South America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

48. Table South America Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

49. Table Middle East & Africa Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in USD Million

50. Table Middle East & Africa Intravenous (IV) Iron Drugs Market Size 2016-2020, by Country, in Volume

51. Table Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Region, in USD Million

52. Table Intravenous (IV) Iron Drugs Market Forecast 2021-2026, by Region, in Volume

53. Table Price Factors List

List of Figure

1. Figure Intravenous (IV) Iron Drugs Industry Chain Structure

2. Figure Global Intravenous (IV) Iron Drugs Market Growth 2016-2020, by Type, in USD Million

3. Figure Global Intravenous (IV) Iron Drugs Market Growth 2016-2020, by Type, in Volume

4. Figure Global Intravenous (IV) Iron Drugs Sales Revenue Share in 2020, by Company, in USD Million

5. Figure Global Intravenous (IV) Iron Drugs Sales Volume Share in 2020, by Company, in Volume

6. Figure North America Intravenous (IV) Iron Drugs Market Concentration, in 2020

7. Figure Europe Intravenous (IV) Iron Drugs Market Market Concentration, in 2020

8. Figure Asia-Pacific Intravenous (IV) Iron Drugs MMarket Concentration, in 2020

9. Figure South America Intravenous (IV) Iron Drugs Market Concentration, in 2020

10. Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Concentration, in 2020

11. Figure Intravenous (IV) Iron Drugs Demand in Nephrology, 2016-2020, in USD Million

12. Figure Intravenous (IV) Iron Drugs Demand in Nephrology, 2016-2020, in Volume

13. Figure Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2016-2020, in USD Million

14. Figure Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2016-2020, in Volume

15. Figure Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2016-2020, in USD Million

16. Figure Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2016-2020, in Volume

17. Figure Intravenous (IV) Iron Drugs Demand in Oncology, 2016-2020, in USD Million

18. Figure Intravenous (IV) Iron Drugs Demand in Oncology, 2016-2020, in Volume

19. Figure Intravenous (IV) Iron Drugs Demand in Cardiology, 2016-2020, in USD Million

20. Figure Intravenous (IV) Iron Drugs Demand in Cardiology, 2016-2020, in Volume

21. Figure Intravenous (IV) Iron Drugs Demand in Others, 2016-2020, in USD Million

22. Figure Intravenous (IV) Iron Drugs Demand in Others, 2016-2020, in Volume

23. Figure Intravenous (IV) Iron Drugs Market Growth 2021-2026, by Application, in USD Million

24. Figure Intravenous (IV) Iron Drugs Market Share in 2026, by Application, in USD Million

25. Figure North America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

26. Figure North America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

27. Figure Europe Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

28. Figure Europe Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

29. Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

30. Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

31. Figure South America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

32. Figure South America Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

33. Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in USD Million

34. Figure Middle East & Africa Intravenous (IV) Iron Drugs Market Size and Growth 2016-2020, in Volume

35. Figure Marketing Channels Overview

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020